ACE2 within the podocyte is known to play a protective role against specific renal diseases, such as diabetic nephropathy [75,76]; however, it remains unknown whether the polymorphism of ACE2 is predictive of SARS-CoV-2–associated FSGS or nephrotic syndrome. Here, ACE2 is linked to focal segmental glomerulosclerosis.